Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

3.65
-0.1400-3.69%
Volume:396.70K
Turnover:1.45M
Market Cap:114.21M
PE:-0.88
High:3.84
Open:3.84
Low:3.56
Close:3.79
52wk High:50.40
52wk Low:3.56
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.29
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.52
PE(LYR):-1.28

Loading ...

Summit Therapeutics up 15% after AstraZeneca makes $2B equity investment

TIPRANKS
·
Sep 29

Summit Therapeutics, AstraZeneca enter clinical collaboration agreement

TIPRANKS
·
Sep 29

AstraZeneca makes $2B equity investment in Summit Therapeutics

TIPRANKS
·
Sep 29

Tempest Therapeutics Strengthens Governance and CAR-T Partnership Framework

TIPRANKS
·
Sep 29

Mirum Therapeutics Reaffirmed as Top Pick as Analyst Hikes Price Target to $195 on Strong Clinical and Regulatory Wins

TIPRANKS
·
Sep 29

Merck in License Pact Worth up to $2.13 Billion with SciBrunch Therapeutics

Dow Jones
·
Sep 28

Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers

GlobeNewswire
·
Sep 28

Transcode Therapeutics reports updated results from Phase 1a TTX-MC138 trial

TIPRANKS
·
Sep 28

Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

GlobeNewswire
·
Sep 28

Press Release: Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer

Dow Jones
·
Sep 28

BlossomHill Therapeutics Presents Preclinical Data on Novel Pan-KRAS Inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer

GlobeNewswire
·
Sep 28

Coiled Therapeutics Director Increases Stake as Precision Oncology Pipeline Advances

TIPRANKS
·
Sep 28

Addex Therapeutics Q2 EPS $(1.52) Up From $(2.90) YoY, Sales $12.650K Down From $44.031K YoY

Benzinga Earnings
·
Sep 28

Press Release: Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate Update

Dow Jones
·
Sep 28

Southern Copper, Toll Brothers, Spruce Power, Structure Therapeutics, Verisign Insider Shake-Up

TIPRANKS
·
Sep 26

Vector Science and Therapeutics Grants Stock Options to Officer

TIPRANKS
·
Sep 26

Silexion Therapeutics Shareholders Reject Capital Structure Changes

TIPRANKS
·
Sep 26

Stoke Therapeutics appoints new independent board director

TIPRANKS
·
Sep 26

Silexion Therapeutics Receives Nasdaq Bid Price Deficiency Notice

TIPRANKS
·
Sep 26

Tempest Therapeutics files to sell 9.53M shares of common stock for holders

TIPRANKS
·
Sep 26